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Abstract 
 
Background: Routine outcome monitoring may improve clinical services but remains 
controversial, partly because the absence of a control group makes interpretation difficult.  
 
Aims: To test a computer algorithm designed to allow practitioners to compare their 
outcomes with epidemiological data from a population sample against data from a 
randomised controlled trial, to see if it accurately predicted the trial's outcome.  
 
Method: We developed an `added value' score using epidemiological data on the 
Strengths and Difficulties Questionnaire (SDQ). We tested whether it correctly predicted 
the effect size for the control and intervention groups in a randomised controlled trial.  
 
Results: As compared with the a priori expectation of zero, the Added Value Score 
applied to the control group predicted an effect size of –0.03 (95% CI –0.30 to 0.24, t = 
0.2, P = 0.8). As compared with the trial estimate of 0.37, the Added Value Score applied 
to the intervention group predicted an effect size of 0.36 (95% CI 0.12 to 0.60, t = 0.1, P 
= 0.9).  
 
Conclusions: Our findings provide preliminary support for the validity of this approach 
as one tool in the evaluation of interventions with groups of children who have, or are at 
high risk of developing, significant psychopathology.  
 
Key Words: Child; Adolescent; Mental health; Risk factors; Developing Countries.  
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Introduction 
 
Although it is clear that a variety of child mental health treatments are efficacious (i.e. 
have an impact under ideal trial conditions), there is still considerable doubt about the 
effectiveness of interventions for children with mental health problems in everyday 
practice.1,2 Given the recent expansion of mental health services for children in Great 
Britain, this uncertainty should preoccupy those involved in service delivery, 
development and policy.2 The publication of routinely collected data on post-operative 
mortality in cardiac surgery may have contributed to a reduction in post-operative 
mortality; although routine outcome monitoring is not without controversy in this and 
other specialties.3 Despite the misgivings of some mental health practitioners, routine 
outcome monitoring has been recommended as a way of driving up the standards of child 
and adolescent mental health services (CAMHS).4 The lack of a control group for 
routinely collected outcome data means that any change after treatment cannot be directly 
attributed to the intervention provided, as other factors may also have changed in the 
interim period. As most CAMHS attenders will score at the higher end of 
psychopathology scales, we would expect their psychopathology scores to reduce in the 
short term because of regression to the mean, attenuation and the fluctuating nature of 
most childhood psychopathology. Regression to the mean occurs as a result of random 
measurement error, so that the second measurement of low and high scorers on any scale 
will tend to score nearer the mean.5 Attenuation refers to the tendency identified in 
epidemiological studies for people to report more problems in the first than subsequent 
interviews, perhaps because of respondent fatigue.6 Childhood psychiatric disorders have 
a chronic and fluctuating course, and as people are often referred when their problems are 
at a peak, in the short term the severity of a child's difficulties are likely to reduce with or 
without active intervention, despite substantial long-term continuity in most types of 
difficulties.7 Could epidemiological data about the longitudinal course of childhood 
psychopathology in the community be used to predict expected change in much the same 
way that growth charts are currently used for height, weight and body mass index?8,9 
Adjusting for expected change would allow services to calculate a more realistic estimate 
of the `added value' of their interventions. We used data from a longitudinal study of 
childhood psychopathology in the community10 to develop a computer algorithm that we 
then tested against data from a randomised controlled trial.11 If the computer algorithm 
worked as a measure of added value, then it should be able to correctly predict the 
outcomes of the intervention and control groups in that trial. If we could demonstrate that 
the algorithm worked as predicted on data from randomised controlled trials, then it 
would support the case for using the same algorithm to assess intervention-related change 
in clinical practice.  
 
Method 
 
Development of the SDQ Added Value Score 
 
The Added Value Score was derived from scores on the Strengths and Difficulties 
Questionnaire (SDQ) completed by parents of children aged 5–16 years participating in 
the British Child and Adolescent Mental Health Survey 2004 (n = 7977) and the follow-
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up 4–8 months later.10 The follow-up study involved all those who were assessed as 
having a psychiatric disorder at baseline (n = 705) and a random sample of those without 
(n = 926). Nearly all (96%) parents participating in the baseline survey agreed to be 
contacted again, and the response rate for the follow-up survey was 72%.  
The SDQ is a well-validated 25-item screening questionnaire composed of five scales 
that assess behaviour problems, hyperactivity, emotional symptoms, peer problems and 
pro-social skills.12 Responses to questions from the first four subscales are added to give 
a total difficulties score. Ratings of child distress and the impact of difficulties on home 
life, friendships, classroom learning and leisure activities are combined to form the 
impact score. The follow-up version of the SDQ (www.sdqinfo.com) asks whether any 
difficulties the child had at baseline have changed, using a five-point Likert-type scale 
(much worse, a bit worse, about the same, a bit better, much better). Questions forming 
the basis of the total difficulties and impact scores were identical at both time points, 
except that the baseline questionnaire asked about difficulties within the previous 6 
months, whereas the follow-up questionnaire was restricted to the previous month.  
 
Parents and young people aged 11 years or over participating in the British Child and 
Adolescent Mental Health Survey 2004 also completed the Development and Well-Being 
Assessment (DAWBA) in the baseline survey.13 The DAWBA is a structured diagnostic 
interview that was administered by lay interviewers. If the family agreed, a shortened 
version was mailed to the child's teacher. All informants were asked to describe any 
problem areas in their own words using a series of prompts, and a small team of 
experienced child psychiatrists used information from the structured questions and 
verbatim transcripts from all informants to allocate diagnoses of psychiatric disorder 
using ICD–10.14 In the validation study of the DAWBA, there was excellent 
discrimination between community and clinical samples.13 Within the community 
sample, children with DAWBA diagnoses differed markedly from those without a 
disorder in external characteristics and prognosis, and there were high levels of 
agreement between the DAWBA and case notes among the clinical sample (Kendall's tau 
b = 0.47–0.70).  
 
When constructing the SDQ Added Value Score, we selected children from the follow-up 
of the British Child and Adolescent Mental Health Survey 2004 who were either rated as 
having a psychiatric disorder (n = 455) in the baseline survey or whose parents had 
contacted primary healthcare or teachers about mental health concerns within the 
previous year (n = 437); given the substantial overlap between these groups, this 
identified a group of 609 children. We had chosen these selection criteria to identify a 
group as similar as possible to children who attend CAMHS. Follow-up SDQ scores were 
influenced by the presence of a psychiatric disorder at baseline (+1.2 SDQ points, 
P<0.001) and contact with primary health or teachers (+1.3 SDQ points, P<0.001), but 
not gender (more boys than girls attend CAMHS).  
 
Some of these children (n = 100, 16%) reported attendance at CAMHS during the follow-
up period, but given that their SDQ scores at the first attendance of CAMHS were not 
available, we were ignorant as to their position on the intervention trajectory. For 
example, a child with a score of 18 in the baseline survey, might then deteriorate acutely 
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2 months later to 24, prompting referral to CAMHS, but given preliminary intervention 
their score might improve to 20 by the 6-month research follow-up. This would lead to 
the child being 2 points worse at follow-up even though there had been improvement 
following preliminary intervention by CAMHS. The mean SDQ Added Value Scores of 
CAMHS attenders were significantly worse than those of children who reported no 
mental health contact (–2.0 (s.d. = 5.1) v. +0.3 (s.d. = 4.6), P<0.001). Thus, we included 
CAMHS attenders in the sample as their exclusion might have left a sample of children 
with milder difficulties who were less representative of children requiring mental health 
services.  
 
The computer algorithm was developed empirically (further information available on 
request) by applying linear regression to the baseline SDQ scores of the 609 children to 
predict their follow-up SDQ total difficulties scores as accurately as possible from their 
initial SDQ scores. We found that the independent predictors of follow-up total 
difficulties score, using stepwise multiple regression were the baseline scores for total 
difficulties, impact and emotional symptoms (more details available from the author on 
request and on www.sdq.info.com). The SDQ Added Value Score is essentially the 
difference between the expected and observed outcome at follow-up and is normally 
distributed, with a mean of zero and a standard deviation of 5 SDQ points. Scores greater 
than zero reflect better than predicted adjustment, whereas scores less than zero indicate 
worse than predicted adjustment. Added value scores showed a modest correlation with 
parents' reports of the change in their children's difficulties since the baseline survey 
(Spearman rho 0.30, P<0.001), but as Fig.1 illustrates the relationship between the two 
measures of change was broadly linear and in the expected direction.  
 
Fig. 1 Mean Strengths and Difficulties Questionnaire Added Value Score and 95% confidence 
intervals in relation to parent's opinion about their child's difficulties at follow-up in the sample from 
which the algorithm was derived. 
 
  
We used stepwise linear regression to examine the extent to which `case-mix' variables or 
context predicted the SDQ Added Value Score. Only 0.6% of the variance of the SDQ 
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Added Value Score was accounted for by the wide range of `complexity' characteristics 
measured in the baseline survey, namely type and severity of diagnosis, age, gender, 
intelligence, physical health, maternal educational level, maternal anxiety or depression, 
family type, family function, family size, income, housing tenure and neighbourhood 
characteristics. In contrast, the variance in SDQ total difficulties explained by these same 
characteristics was 35.9% at baseline and 24.2% at follow-up, demonstrating that the 
influence of case complexity on the SDQ Added Value Score was very small in this 
sample, and is certainly much reduced compared with the influence of these 
characteristics on raw scores. This suggests that providing the SDQ Added Value Score is 
used with children who have or are at high risk for impairing psychopathology (because 
this mirrors the children that it was derived from); the function of the algorithm may not 
vary a great deal in different contexts.  
 
Study design and participants 
 
The Welsh Sure Start randomised controlled trial was selected to test the SDQ Added 
Value Score because it used the SDQ with the impact supplement, had a follow-up 4–8 
months later and detected a difference between the control and intervention groups. It 
was the only trial meeting all these criteria that we were able to locate by searching trial 
registries for trials using the SDQ as an outcome measure and by contacting researchers 
running trials of child mental health interventions. The trial tested the Incredible Years 
Basic Parenting Programme; a 12-week group intervention aimed at reducing behavioural 
problems in children.15 Parents were randomly allocated on a 2:1 ratio to immediate or 
delayed treatment.11 The programme has a strong evidence-base in the prevention and 
treatment of conduct disorder, and is one of two treatments for conduct disorder 
specifically recommended by the National Institute for Health and Clinical Excellence.16 
The trial took place in 11 Sure Start areas in North and Mid Wales, delivering a 
standardised behavioural programme in community settings using existing staff.11 
The children were aged 3 and 4 years old and at risk of conduct disorder defined as 
scoring above cut-off on one or both of the intensity or total problem scales on the 
Eyberg Child Behaviour Inventory (ECBI).17 The trial reported outcomes according to 
both intention-to-treat and a per protocol analyses; the intention-to-treat analysis used the 
last score carried forward where data was missing. Our re-analysis was restricted to the 
per protocol groupings since only these individuals had the complete baseline and 6-
month follow-up SDQ scores (n = 86) that are required to calculate the added value and 
change scores. As this analysis aimed to evaluate how accurately the SDQ Added Value 
Score could predict the effect size obtained by the per protocol analysis in the trial, the 
attrition biases inherent in per protocol analyses are likely to be irrelevant. For the 
purposes of this paper, we were interested in whether the SDQ Added Value Score could 
reflect the effect of treatment as reported, rather than estimating the true effect of the trial 
intervention adjusting for participants who had dropped out.  
The intervention in the original trial was highly effective according to the primary 
outcome measure (ECBI problem scale: effect size 0.70, 95% CI 0.33–1.06) with weaker 
effects according to the more general SDQ (effect size 0.37, 95% CI 0.005–0.73 
according to SDQ total difficulties score). These effect sizes were calculated from 
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analysis of covariance of the response, taking account of area, treatment and baseline 
measurement. 
  
Statistical analysis 
 
The analysis was conducted using SPSS for Windows 15.0. The Added Value Scores and 
change scores were calculated for each child using the equations below.  
 Raw Added Value Score (in SDQ points) = 2.3 + 0.8*baseline total difficulties 
score + 0.2*baseline impact score – 0.3* baseline emotional difficulties subscale 
score –  follow-up total difficulties score.  
 Raw change score (in SDQ points) = baseline total difficulties score – follow-up 
total difficulties score  
 
Effect sizes were calculated from the raw scores for the both added value and change 
scores by dividing the raw scores by their respective standard deviations in normative 
samples (5.8 for the total difficulties score, 5 for the Added Value Score; see 
www.sdqinfo.com). If the algorithm for the SDQ Added Value Score worked as we 
expected, the Added Value Score for the control group should be zero (i.e. no change as 
no intervention), and the Added Value Score for the intervention group should 
approximate to the effect size reported in the original trial (0.37). We tested whether the 
observed mean effect sizes for the SDQ Added Value Score and simple change scores 
differed significantly from the expected values in the intervention arm (effect size 
reported by the trial) and the control arm (no effect expected as no intervention) using a 
one-sample t-test. The one-sample t-test compared the mean of the experimental sample 
(i.e. the SDQ Added Value Score or the change scores) with a comparison mean set with 
the expected value for each group (i.e. 0.37 for the intervention group and 0 for the 
control group).  
 
Results 
 
As Table 1 illustrates, the sample from which the SDQ Added Value Score was derived 
and evaluated resembled the Sure Start sample in gender but differed markedly from it in 
mean age and more modestly in the mean level of emotional and behavioural difficulties. 
If the SDQ Added Value Score failed to predict the impact of the intervention as 
predicted, we would not know if this was because the algorithm did not work or because 
the context was so different. However, if the SDQ Added Value Score functioned as 
expected, these differences would provide evidence for the algorithm's robustness to 
contextual change, in line with the weak relationship between complexity factors and the 
Added Value Score in the sample from which it was derived. By comparison with the rest 
of the British Child and Adolescent Mental Health Survey 2004, the SDQ Added Value 
Score derivation sample was slightly older, more often male, and had a much higher level 
of emotional and behavioural difficulties; as would be expected for a subsample designed 
to resemble the sorts of children seen by mental health clinics.  
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Table 1 : Comparison of the samples from which the Strengths and Difficulties Questionnaire Added 
Value Score (SDQ AVS) was derived and evaluated (Welsh Sure Start Trial) 
 BCAMHS 
2004, 
n = 7977
a
 
SDQ AVS 
derivation 
sample, 
n = 609
a
 
Welsh Sure 
Start trial, 
n = 133 
Age, years    
   Range 5-16 5-16 3-4 
   Mean (s.d.) 10.5 (3.4)* 11.0 (3.3) 3.9 (0.5)* 
Male gender, % 51.5*  61.1 60.2 
SDQ parental total difficulties 
score at baseline, mean (s.d.) 
7.9 (5.9)* 15.5 (7.2) 17.7 (5.8) 
a.
 SDQ AVS derivation sample is a subsample of the British Child and Adolescent Mental Health Survey 
(BCAMHS) sample two. Chi-squared and t-tests use the SDQ derivation sample as the reference group for 
comparison with the remainder of the BCAMHS and with the Welsh Sure Start trial. *P<0.001. 
 
As shown in Table 2, the effect size based on the Added Value Score of the control group 
was very close to zero (–0.03), which is the a priori predicted value for a group who 
received no treatment. By contrast, the effect size based on simple change scores for the 
control group was 0.35, presumably indicating the failure to account for regression to the 
mean, attenuation and spontaneous improvement. Likewise, the effect size for the Added 
Value Score of the intervention group was very close to the effect size reported in the 
original trial (trial 0.37, Added Value Score 0.36). The effect size for the change score 
among the intervention group was 0.65, representing a considerable overestimate of the 
impact of the intervention in the trial as assessed by the SDQ total difficulties score.  
 
Table 2 : Comparison of the added value Strengths and Difficulties Questionnaire (SDQ) scores and 
change scores with the expected effect sizes for control and intervention groups separately 
 Effect size in standard deviation units (95% confidence interval) 
Expected value
1
 Added Value Score Change score 
Control group 0 
 
-0.03 (-0.30-0.24) 0.35 (0.12 - 0.59)* 
Intervention group 0.37 (0.005-0.73) 0.36 (012-0.60) 0.65 (0.43 - 0.87)** 
1 The expected value for the control group was predicted as 0 a priori, because they received no treatment, 
while the expected value for the intervention was the effect size reported from the original trial according to 
the SDQ. * p<0.05, **p<0.01 value significantly different to that expected. 
 
The effect sizes calculated from the Added Value Score were not significantly different 
to the expected values for either arm of the trial (intervention t = 0.1, P = 0.9; control t = 
0.2, P = 0.8), whereas the effect sizes derived from the change scores were significantly 
different to the expected values in both the intervention (t = 2.5, P = 0.01) and control (t = 
2.9, P = 0.005) groups.  
 
Discussion 
 
Substantive findings 
 
The SDQ Added Value Score behaved as predicted by producing an effect size close to 
zero for the control group and an effect size for the intervention group that was virtually 
identical to that calculated using SDQ total difficulties scores in the original trial. By 
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contrast, simple change scores suggested a substantial impact from being on a waiting list 
in the control group, and also considerably overestimated the effectiveness of the 
intervention. These findings provide preliminary support for the use of the SDQ Added 
Value Score to assess the effectiveness of interventions with children who have, or are at 
high risk of, impairing psychopathology. This is reassuring since a public service 
agreement based on the SDQ Added Value Score has provisionally been recommended 
for adoption in England in 2009.18 Nevertheless, we have only validated the Added 
Value Score by re-analysing a single trial and further replication is a priority.  
Only a very small proportion of the variance of the SDQ Added Value Score was 
explained by the baseline characteristics of the children participating in the British Child 
Mental Health Survey 2004, which is not surprising given that case complexity measures 
based on factors theoretically important to the outcome of child mental health 
interventions are not closely related to outcome when studied in routine clinical 
services.19 However, concerns about the difficulty in measuring case complexity and 
case mix remain a major impediment to routine outcome monitoring.20 It is possible that 
the SDQ Added Value Score might be influenced by characteristics that were not 
measured in the baseline survey, but those factors commonly thought to contribute to 
case complexity in child mental health were examined. It may be that case complexity 
adds to practitioner workload in child mental health services, in terms of the number of 
professionals involved, the number of appointments offered and the increased liaison 
required with multiple agencies, but that more complex cases do not inevitably have a 
worse outcome. This would explain practitioners concerns about case complexity and is 
an important empirical question for those involved in service development. 
  
Limitations 
 
In the Incredible Years trial, 53% of the children were 3 years of age, whereas the version 
of the SDQ used is aimed at 4- to 16-year-olds.12 Younger children are likely to exhibit 
argumentative or disobedient behaviour rather than more severe difficulties tapped by 
some questions in the school-aged version of the SDQ (e.g. lying or stealing). It may 
have underestimated behaviour problems and any subsequent change. However, these 
two versions of the SDQ are identical except for the substitution of two items relating to 
oppositionality for the conduct disorder questions and the softening of one item relating 
to overactivity and inattention in the version for 3- to 4-year-olds, so that any 
underestimate in a high-risk sample is likely to be small. More importantly in relation to 
the current study, an underestimate in the level of behaviour problems is immaterial as 
long as there was a statistically significant difference between the intervention and 
control arms according to the SDQ that would allow us to test the algorithm. The 
important issue was whether the Added Value Score could replicate the SDQ effect size 
estimated by means of a randomised controlled trial (the `gold standard'). That the SDQ 
Added Value Score produced results so similar to the trial in 3- to 4-year-olds despite 
being derived on an older population (5–16 years) provides some evidence that the 
algorithm can work in populations other than that from which it was derived. 
  
As the Incredible Years randomised controlled trial did not use the follow-up version of 
the SDQ, we were unable to examine how the Added Value Score compared with the 
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responses of parents in the trial sample to the additional questions in the follow-up SDQ 
about whether their child's difficulties had improved or whether the intervention had 
helped in other ways. We were only able to investigate this source of face validity in the 
sample from which the algorithm was derived with obvious limitations. The only 
difference between the follow-up and ordinary versions of the SDQ is the time period that 
the informant is asked about: 1 month and 6 months respectively. The shorter time period 
at follow-up is thought to allow time for the intervention to have an impact and to focus 
the informant's mind on more recent functioning. The longer time period used in the trial 
may have diminished the difference between the trial and intervention groups, but as 
stated above, the key test for the algorithm was whether it could replicate the findings of 
the trial, rather than precise estimation of the effectiveness of the intervention.  
Clinical and policy applications 
 
The original trial reported a larger effect size (0.70, 95% CI 0.33–1.06) according to the 
Eyberg Child Behaviour Inventory, which is a specific measure of behavioural 
difficulties that is designed for 2- to 16-year-olds, than with the more broadly focused 
SDQ (0.37, 95% CI 0.005–0.73). This illustrates a recognised tendency for broad 
outcome measures to produce smaller effect sizes than specialised measures.21 Such 
effects needs to be acknowledged when broad outcome measures are used in routine 
outcome monitoring so that low effect sizes do not inappropriately discourage 
practitioners and their commissioners. Although the SDQ has the advantage of allowing 
comparison across children with disparate problems and access to general population 
norms, clinicians may want to supplement routine monitoring of the outcome of all cases 
with the SDQ with disorder-specific scales.  
 
The fact that the SDQ is a broad focus measure is one reason why it is unrealistic to 
expect CAMHS practitioners in everyday practice to replicate the effect sizes of 0.5 or 
greater that are often reported in efficacy trials using specialised measures that focus on 
the problem being treated. In addition, efficacy studies typically involve children without 
comorbid difficulties, and results for such children do not necessarily translate easily to 
children attending mental health services, where comorbidity is the rule.20,22 Other 
important caveats for the appropriate use of the Added Value Score are set out in the 
Appendix.  
 
As the formula was derived from children who had psychiatric disorders or whose 
parents were concerned about their child's mental health, both of which reduced the level 
of spontaneous improvement over the subsequent 6 months, the SDQ Added Value Score 
will underestimate the level of spontaneous improvement and thus overestimate the 
impact of any intervention if applied to children with milder problems. It is therefore 
inappropriate to use the current algorithm to assess primary prevention or interventions 
among children with low levels of initial difficulty. Although the confidence intervals 
around the scores of an individual child are too wide for the SDQ Added Value Score to 
be a reliable index of that child's progress, our findings suggest that for groups of 
children treated by a clinician, team or clinic it can detect significant change. 
Examination of responses to the SDQ at baseline and follow-up may help case 
formulations or clinical discussions on an individual level.  
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The concept of clinically significant change, defined as a statistically reliable return to 
normal functioning, and the related reliable change index have been proposed as tools for 
evaluating the impact of psychological interventions.23 However, the cut-off points 
denoting clinical significance are inevitably arbitrary, a return to normal function is not 
expected in many children (autism for instance), and this approach may not be 
appropriate for individuals with comorbid problems (most of those attending child mental 
health services).23,24 As the SDQ Added Value Score relies heavily on the impact scores 
at baseline, it detects therapeutic impact on function as well as symptoms, and is not 
constrained by comorbidity or where a return to normal function is not feasible. In 
addition, it uses a quasi-experimental comparison group, rather than essentially arbitrary 
cut-off points to assess clinical significance. The mean level of symptoms in a population 
is related to the prevalence of psychological distress in that population, and the `normal' 
level of symptoms or impairment among children is not known.  
 
Lambert has used a huge database of responses to one particular questionnaire to provide 
feedback to therapists about how adult service users are responding to treatment.25 The 
questionnaire is completed prior to each session and therapists provided with feedback 
produce better results among individuals who are not responding or deteriorating than 
therapists who do not receive this advice. Lambert has developed a measure for children 
and young people, but is yet to establish its psychometric properties; there is not yet a 
large database to base practice on, and although promising, this method is dependent on 
clinically significant change calculations, with all the difficulties discussed above.  
A recent review suggests that the publication of outcome data stimulates quality 
improvement activity; although the papers included were dominated by cardiac surgery 
and there was inconsistent evidence of improved effectiveness.26 Australia leads the 
world in routine outcome monitoring in mental health, including CAMHS, and in adults 
has been able to demonstrate the effectiveness of mental health services from centrally 
collated mandatory data (see www.mhnocc.org).27 
 
Even if demonstrated to be reliable with repeated testing, the SDQ Added Value Score is 
just one tool for assessing the quality of services. For the best assessment of service 
provision and development, service should collect a combination of measures such as 
clinician and service user-rated questionnaires on outcome, satisfaction reported by 
parents and young people, direct observational measures and process measures. The best 
assessment of quality will be achieved by triangulating data from different sources and 
looking for explanations for both good and poor results. As the follow-up study used to 
generate the Added Value Score only collected SDQs from parents, there are not yet 
equivalent Added Value Scores measuring the impact of interventions as reported by 
teachers or young people themselves.  
 
As Lilford et al state, the emphasis in outcome monitoring should be on encouraging 
improvements by all rather than seeking to `name and shame' those who have poor results 
in some areas: most services will have a spectrum of results.20 Ranking services or 
measuring them against an average measure is certain to undermine morale, because 
someone has to be the `worst' and by the laws of statistics approximately half will be 
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`below average'. Moreover, such an exercise fails to inform us about the absolute quality 
of the services provided; one service will still be ranked lowest, even if every service 
exceeded every performance target set.  
 
A recent comparison of hospital episode statistics and the central cardiac audit database 
suggested that incomplete and/or inaccurate data can lead to highly misleading findings; 
which if placed in the policy or public domain, can have a highly adverse impact on 
services.28 Complete and accurate data is therefore crucial, and most services will need 
additional resources to develop high-quality data management programmes with 
universal procedures for entry and regular auditing.28 Only in this way will we be able to 
draw reliable conclusions about what works for improving child mental health in routine 
clinical practice.  
 
The SDQ Added Value Score is an outcome-based measure of CAMHS quality. Lilford 
and colleagues argue that measures of process are preferable to outcome measures, in that 
process measures are less likely to create perverse incentives and are better correlated 
with quality.20 Although we strongly agree that it is important to reflect on the process 
and content of care, we do not believe that all outcome measures should necessarily be 
excluded from quality evaluations. The SDQ measures the type of difficulties that lead 
families to seek help and their impact, which are legitimate targets of intervention. The 
SDQ Added Value Score seems to be relatively robust to the complexity factors which 
Lilford et al argue will tend to influence many outcome measures. Being completed by 
parents, the SDQ Added Value Score is less vulnerable than clinician-rated measures to 
distortion to meet management targets and arguably less likely to create perverse 
incentives.20 It is also important to remember that child mental health is one area where 
we actually have relatively limited data as to which `processes' do improve child mental 
health when delivered in routine clinical settings. We therefore believe that, if the 
encouraging findings from this first evaluation can be replicated, then the SDQ Added 
Value Score may prove an important tool for evaluating CAMHS quality.  
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Appendix 
Caveats for clinical practice 
a. The Added Value Score is only calibrated for use with therapeutic or targeted 
interventions and will overestimate change in groups with low levels of 
psychopathology. It should not be applied to universal interventions.  
b. The Added Value Score is a tool for evaluating the impact of interventions on 
groups of children, and the confidence intervals around the scores of 
individual children will be too wide to interpret in most instances.  
c. The Added Value Score requires follow-up to occur between 4 and 8 months 
after the initial measure. Follow-up after a fixed interval is preferable to 
administration at discharge because of the risk that discharge may follow soon 
after a spontaneous improvement, and thereby capitalise on chance remission.  
d. The Added Value Score is based on the SDQ, which is a `wide angle' measure. 
Clinicians may want to supplement the SDQ with more specific outcome 
measures relating to each child's individual problems.  
e. The use of multiple measures (clinician, parent, child, process, satisfaction, 
direct observation) will provide commissioners, practitioners and policy 
makers with richer data for improving services.  
f. Services need to aim for high response rates from parents in order to obtain 
representative data. This requires resources.  
 
 
